INTRODUCTION
Over the last 2 decades, knowledge of patient safety has advanced substantially. Many hospital acquired harms once thought inevitable are not preventable. [1] [2] [3] [4] The United States government, largely through the Centers for Medicare & Medicaid Services (CMS) and the Agency for Healthcare Research and Quality, has promoted measuring, reporting, and decreasing patient harm. In an effort to decrease harm, the CMS's Partnership for Patients program defined a list of 9 hospital-acquired conditions (HACs), and funded Hospital Engagement Networks to decrease occurrence of these events by 40% in 3 years over their baseline rates 5 (Table 1) . These HACs are useful for comparisons across similar hospitals and are worthy targets for quality improvement efforts, given common definitions and an increasing literature base describing effective prevention strategies. In a separate but similar CMS program, the Hospital Acquired Condition Reduction Program utilizes HACs that are similar to those in the CMS Partnership for Patients program. 6 Recognizing that HACs represent only a portion of patient harm (temporary or permanent injury resulting from the patient's care rather than disease 6 ), CMS notes in its Partnership for Patients program that "the Partnership will target all forms of harm" and produce guidance for reducing "all-cause harm." 6 Other forms of patient harm, such as unplanned extubation, surgical complications, sepsis, clostridium difficile, and delirium, still contribute substantially to harm-related morbidity and resource utilization. [7] [8] [9] [10] [11] In response, policymakers discuss all-cause harm identification as a desirable and achievable goal, yet there is no requirement for consistent application of allcause-harm measurement. 12 Previous studies have identified harm using a trigger tool to detect specific "triggers," defined as medical record-based hints, presented in a patient's medical record that may be associated with harm. 13, 14 In a multisite pediatric study, the rate of harm was reported as 40 harms per 100 admissions. 15 These results are consistent with findings in pediatrics and adult medicine. 16, 17 To better understand the proportion of the total harm burden that HACs represent, we compared the number of CMSdefined HACs to the total harms identified using a previously published pediatric trigger tool.
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METHODS
Design/Setting/Patients
Data were originally collected for a cross-sectional, retrospective study aimed to pilot test a trigger tool that would detect the most common causes of harm in pediatric inpatient settings. The method of data collection and harm identification using the Pediatric All-Cause Harm Measurement Tool (PACHMT) at 6 participating academic children's hospitals has been recently described. 15 Briefly, we applied the pediatric trigger tool to 100 randomly selected patient charts per hospital (600 total) from February 2012. Eligible patient records were inpatients younger than 22 years of age, had a length of stay between 24 hours and 6 months, and were discharged in February 2012. The exclusion criteria in our original article and this article were patients admitted for rehabilitation, to the newborn nursery, to day-treatment areas, or with a primary discharge diagnosis related to psychiatric or obstetric care. 15 This approach mirrors that used by other authors. 16 The PACHMT was designed to identify the most common causes of pediatric harm, using a trigger list that includes medical triggers, medication administration triggers, health care-associated infections, perioperative triggers, readmission triggers, and resuscitation/ death triggers. However, the PACHMT did not have specific triggers for Falls, Surgical Site Infections, and Venous Thromboemboli. Trained reviewers identified triggers in the medical record, assessed them, and documented the presence of harm; a secondary reviewer at each site confirmed the findings. From the 600 patient charts evaluated, 240 harmful events were identified ( Table 2) . Of the 240 harms, the PACHMT detected 1,093 triggers, resulting in identification of 204 (85.0%) of the total harms identified. 15 Institutional review board waiver or approval for this study was granted at each site.
Intervention
For this investigation, the 240 previously identified harms were individually examined by 2 co-authors (D.S., D.K.) "Other" includes the following: diarrhea (n = 3); hyperthermia/fever (n = 3); intubation complications/post extubation stridor (n = 3); cardiac arrest (n = 2); decubitus ulcers (n = 2); dehydration (n = 2); gastrointestinal bleed (n = 2); insulin use complication or misuse (n = 2); iatrogenic renal injury, renal failure, renal dysfunction (n = 2); other (n = 2); death (n = 1); seizures (n = 1); and weakness/loss of strength (n = 1 
Outcomes
The primary outcome was the percentage of overall harm identified with the PACHMT that were also identified as HACs.
Statistical Analysis
We summarized harm identified as HACs by both co-authors and compared the level of agreement using Cohen's Kappa.
RESULTS
Reviewer 1 identified 62 harm events as HACs and reviewer 2 identified 56 harm events as HACs. Agreement between the 2 reviewers was high (Kappa = 0.775). Upon initial review, 49 of these events had agreement between the 2 reviewers. The disagreements were subsequently reviewed, and after reconciling differences, an additional 9 harm events were reclassified as HACs. Of these 9 harm events, 7 were reclassified as adverse drug events, 1 was reclassified as a surgical-site infection, and 1 was reclassified as a ventilator-associated pneumonia. For each event, both reviewers revisited and discussed the original event description together, comparing the event to the definitions of HACs determined by the Partnership for Patients program, and the harm event was resolved when consensus was reached. HACs represented 58 (24.2%; 95% confidence interval: 9.1-31.7%) of the total 240 harms identified by the PACHMT (Table 1) . A complete list of the total 240 harms and their frequency is shown in Table 2 .
DISCUSSION
To our knowledge, this is the first study that identifies the percentage of all-cause harm due specifically to HACs. At 24.2%, HACs represent only a subset of the total harm detected by a trigger tool that patients experience and therefore the substantial majority of harms are not HACs. The heavy regulatory focus placed on identifying, reporting, and improving HACs is useful, but its impact relative to overall harm may be limited. We recognize each HAC has varying influence on morbidity and resource utilization, but other preventable harms still have a significant impact on the overall harm burden patients experience. [7] [8] [9] [10] [11] In a recent press release, the Partnership for Patients Hospital Engagement Network outlined a list of additional harms unaddressed by HACs that should be accounted for to pursue safety across the board. 18 This may in part explain the lack of significant progress witnessed in multiple studies in reducing overall harm rates in the past 2 decades, even in the face of substantial efforts, many of them successful, to reduce HACs and other discrete harms.
2 Also, because the scope of harm appears much broader, working on specific types of harms 1 at a time will likely not be transformational. Rather, establishing a true culture of safety, identifying and addressing root causes within hospital systems that drive multiple types of harms, and focusing on integrating high reliability principles and human-centered design across hospital care processes may have greater impact.
In the original study, for the 240 harms identified, only 22 (9.2%) were also identified within the hospital's voluntary reporting system. 15 Therefore, voluntary reporting of harms appears to underestimate the total burden of harm occurring in hospitals. Unfortunately, many types of harm not captured in the HACs, and infrequently reported in voluntary reporting systems, may go entirely unaddressed.
Although HACs do not capture all events, it is important to recognize their focus has been an improvement over relying solely on voluntary reporting for harm identification. Additionally, HACs have standard definitions and a body of best practices, which help target them. Voluntary reporting enhances understanding of safety vulnerabilities, even though it captures only a small fraction of all harms. These harm identification methods should not be viewed as competitive, but rather as complementary. As trigger tools and other methodologies come into usage, they provide a more systematic, comprehensive measurement of harm rates that complement and enhance these approaches. This will benefit providers, health care systems, and most importantly, patients.
This study has several limitations. Several HACs did not have an associated trigger (eg, falls, surgical-site infections, or venous thromboemboli) and may have been present in a patient record but not identified in our study. Also, because medical record review and HAC reviews were conducted at 2 distinct points in time (medical record reviews done as part of an earlier study), some HACs were not described in enough detail to confirm or deny their existence. Lastly, we recognize that at the time of original data collection, HAC definitions had not been fully developed. Future studies should attempt to review more recent medical records to determine if the percentage of harm burden that HACs represent has changed with the development of succinct definitions of HACs.
Importantly, 
CONCLUDING SUMMARY
In a 6-hospital effort to examine safety events, 1 in 4 identified adverse events identified by a pediatric-specific trigger tool met the definition of a HAC. Although substantial effort is focused on identifying and minimizing HACs, there remain many harm events that are unidentified and unmanaged using this approach. 
